United States

Back to map

Showing 1-10 of 327 grants

Title Institution Researcher Program Duration Total Award Amount
ALIGN-T1D Start-Up Secretariat Clinton Health Access Initiative (CHAI) Nine Steensma Mission 01-October-2025 to 31-March-2027 $2.348.396,21
Thermally responsive minimally invasive proangiogenic placeholder for cell transplantation for Type 1 Diabetes University of Washington Patrick Stayton Cures 01-November-2025 to 31-October-2028 $894.965,96
Clinical Translation of T-1123, an Ultra-rapid, Concentrated, Temperature stable Novel Insulin Analog Invictus Therapeutics, LLC Robyn Day Improving Lives 15-October-2025 to 31-May-2027 $1.437.112,00
A Cure for Type 1 Diabetes University of Massachusetts Medical School David Harlan Cures 01-October-2025 to 30-September-2029 $16.000.000,00
Evaluating the Impact of High-Risk HLA-DR Serotypes on the Cellular Neighborhood of the Pancreatic Islets: Towards Early Identification of T1D Disease Risk and Prevention Missouri University of Science and Technology Gina Yosten Cures 01-October-2025 to 30-September-2028 $740.097,60
Combination therapy with STX4 activating small molecules or small activating RNA together with harmine to stimulate beta-cell regeneration and enhance functional beta-cell mass Beckman Research Institute of the City of Hope Debbie Thurmond Cures 01-October-2025 to 30-September-2028 $1.050.000,00
Dual Beta-cell Regenerative and Immunomodulatory Endogenous Agonist as a Replacement Therapy for Type 1 Diabetes Rector & Visitors of the University of Virginia Gordon Laurie Cures 01-October-2025 to 30-September-2027 $300.000,00
Understanding common tissue tolerance mechanisms in autoimmunity Massachusetts General Hospital Gary Reynolds Cures 01-September-2025 to 31-August-2026 $150.000,00
A glucose-responsive cannula of insulin delivery Cornell University Bo Wang Improving Lives 01-March-2023 to 28-February-2025 $198.731,24
Safety and efficacy assessment of Tegoprubart and calcineurin inhibitors- free immunosuppression therapy for pancreatic islet transplantation in patients with t1DM and chronic kidney disease. The University of Chicago Piotr Witkowski Cures 01-September-2025 to 31-August-2029 $8.500.000,00